199 related articles for article (PubMed ID: 22202376)
1. [Combination chemotherapy using docetaxel, cisplatin, and S-1 for far advanced gastric cancer].
Hamakawa T; Kurokawa Y; Takiguchi S; Takahashi T; Yamasaki M; Miyata H; Nakajima K; Mori M; Dok Y
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2342-4. PubMed ID: 22202376
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases.
Fushida S; Fujimura T; Oyama K; Yagi Y; Kinoshita J; Ohta T
Anticancer Drugs; 2009 Sep; 20(8):752-6. PubMed ID: 19543076
[TBL] [Abstract][Full Text] [Related]
3. [A case of advanced gastric cancer showing pathological CR after neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 combination].
Usuda A; Nashimoto A; Yabusaki H; Nakagawa S; Matsuki A; Tsuchiya Y; Takii Y; Nomura T; Maruyama S; Homma K
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1687-90. PubMed ID: 21996968
[TBL] [Abstract][Full Text] [Related]
4. [A case report-highly advanced gastric cancer leading to perforation during neoadjuvant chemotherapy with docetaxel, cisplatin and S-1].
Mihara K; Egawa T; Kemmochi T; Irino T; Okamura A; Inaba Y; Eto E; Segami K; Ito Y; Hayashi S; Nagashima A
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2357-9. PubMed ID: 22202381
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.
Hirakawa M; Sato Y; Ohnuma H; Takayama T; Sagawa T; Nobuoka T; Harada K; Miyamoto H; Sato Y; Takahashi Y; Katsuki S; Hirayama M; Takahashi M; Ono M; Maeda M; Takada K; Hayashi T; Sato T; Miyanishi K; Takimoto R; Kobune M; Hirata K; Kato J
Cancer Chemother Pharmacol; 2013 Mar; 71(3):789-97. PubMed ID: 23338051
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002.
Ito S; Sano T; Mizusawa J; Takahari D; Katayama H; Katai H; Kawashima Y; Kinoshita T; Terashima M; Nashimoto A; Nakamori M; Onaya H; Sasako M
Gastric Cancer; 2017 Mar; 20(2):322-331. PubMed ID: 27299887
[TBL] [Abstract][Full Text] [Related]
7. Preoperative systemic and intraperitoneal chemotherapy consisting of S-1, cisplatin and docetaxel in patients with marginally resectable gastric cancer.
Kurokawa Y; Hamakawa T; Miyazaki Y; Takahashi T; Yamasaki M; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
Anticancer Res; 2015 Apr; 35(4):2223-8. PubMed ID: 25862882
[TBL] [Abstract][Full Text] [Related]
8. Early results of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S-1 and docetaxel/cisplatin/S-1 as neoadjuvant chemotherapy for locally advanced gastric cancer.
Aoyama T; Nishikawa K; Fujitani K; Tanabe K; Ito S; Matsui T; Miki A; Nemoto H; Sakamaki K; Fukunaga T; Kimura Y; Hirabayashi N; Yoshikawa T
Ann Oncol; 2017 Aug; 28(8):1876-1881. PubMed ID: 28486692
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 for resectable locally advanced gastric cancer.
Migita K; Nashimoto A; Yabusaki H; Matsuki A; Aizawa M
Int J Clin Oncol; 2016 Feb; 21(1):102-9. PubMed ID: 26017926
[TBL] [Abstract][Full Text] [Related]
10. Short-term results of a phase II study of preoperative docetaxel/cisplatin/S-1 therapy for locally advanced gastric cancer.
Tsuchida K; Sato T; Aoyama T; Atsumi Y; Kano K; Maezawa Y; Kazama K; Numata M; Yamada T; Tamagawa H; Murakami H; Oshima T; Saeki H; Cho H; Yukawa N; Yamamoto Y; Masuda M; Rino Y
Jpn J Clin Oncol; 2021 Mar; 51(3):371-378. PubMed ID: 33283236
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and S-1 for Resectable Advanced Esophageal Cancer.
Hayata K; Ojima T; Nakamori M; Nakamura M; Katsuda M; Kitadani J; Takeuchi A; Tabata H; Maruoka S; Yamaue H
Anticancer Res; 2018 Sep; 38(9):5267-5273. PubMed ID: 30194177
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of S-1 plus docetaxel combination therapy for patients with advanced gastric cancer].
Nishiwaki H; Yamada T; Tachi K; Iwasaki H; Hori Y; Umemura S; Yamakawa Y; Kurimoto T; Ban T; Fujiwara K; Hayashi K; Nemoto A; Shiroko J; Orito E
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1663-6. PubMed ID: 19838024
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of patients with advanced gastric cancer undergoing S-1/CDDP combined neoadjuvant chemotherapy].
Kikuchi D; Ishii Y; Saitou M; Yamada M; Takenoshita S
Gan To Kagaku Ryoho; 2011 Jul; 38(7):1113-7. PubMed ID: 21772093
[TBL] [Abstract][Full Text] [Related]
14. Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer.
Sasaki K; Onodera S; Otsuka K; Satomura H; Kurayama E; Kubo T; Takahashi M; Ito J; Nakajima M; Yamaguchi S; Miyachi K; Kato H
Med Oncol; 2017 Aug; 34(8):139. PubMed ID: 28707042
[TBL] [Abstract][Full Text] [Related]
15. [A case of advanced gastric cancer responding to neoadjuvant chemotherapy with S-1 and CDDP combination].
Terakura M; Ikebe T; Nishioka T; Horiike M; Kaneko M
Gan To Kagaku Ryoho; 2010 May; 37(5):887-9. PubMed ID: 20495321
[TBL] [Abstract][Full Text] [Related]
16. [Clinical trials of neo-adjuvant chemotherapy for advanced gastric cancer with peritoneal dissemination].
Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamazaki M; Nishida T; Doki Y
Gan To Kagaku Ryoho; 2008 Nov; 35(12):1996-8. PubMed ID: 19106502
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1, followed by gastrectomy with D2 lymph node dissection for high-risk advanced gastric cancer: results of the KDOG1001 trial.
Hosoda K; Azuma M; Katada C; Moriya H; Mieno H; Ishido K; Ema A; Ushiku H; Wada T; Washio M; Watanabe A; Higuchi K; Tanabe S; Koizumi W; Watanabe M; Yamashita K
Gastric Cancer; 2019 May; 22(3):598-606. PubMed ID: 30284080
[TBL] [Abstract][Full Text] [Related]
18. [A case of cervical lymph node recurrence of advanced gastric cancer responding to combination therapy of S-1, CDDP and docetaxel].
Sugishita H; Ishida N; Yoshida M; Sato K; Doi T; Horiuchi A; Watanabe Y
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1385-8. PubMed ID: 20647733
[TBL] [Abstract][Full Text] [Related]
19. Low-dose docetaxel and cisplatin combination chemotherapy for stage II/III gastric cancer showing resistance to S-1 adjuvant chemotherapy: a phase I study.
Kunisaki C; Ono HA; Hasegawa S; Oshima T; Fujii S; Tokuhisa M; Izumisawa Y; Takagawa R; Kimura J; Kosaka T; Makino H; Akiyama H; Endo I
J Chemother; 2012 Dec; 24(6):364-8. PubMed ID: 23174102
[TBL] [Abstract][Full Text] [Related]
20. [A case of advanced gastric cancer responding to combined systemic and intraperitoneal chemotherapy with docetaxel, cisplatin, and S-1].
Yasui T; Mukubo H; Sato N; Kita I; Fushida S
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2229-31. PubMed ID: 24394068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
